SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-14-001580
Filing Date
2014-05-19
Accepted
2014-05-19 17:29:53
Documents
3
Period of Report
2014-05-14
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-05192014_020546.htm 8-K 15887
2 ex10-05192014_020546.htm EX-10 83993
3 ex10-05192014_020547.htm EX-10 35239
  Complete submission text file 0001415889-14-001580.txt   136464
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54014 | Film No.: 14855696
SIC: 2834 Pharmaceutical Preparations